Trexquant Investment LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$83.14 - $145.99 $291,322 - $511,548	3,504 New	3,504 $511,000
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $733,269 - $1.03 Million	-7,418 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $487,956 - $779,038	7,418 New	7,418 $720,000
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $761,856 - $1.09 Million	-11,891 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $773,747 - $1.17 Million	11,891 New	11,891 $1.02 Million
Q1 2019 May 13, 2019	SELL	$34.52 - $53.29 $216,647 - $334,448	-6,276 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $186,711 - $269,240	6,276 New	6,276 $232,000
Q1 2018 May 03, 2018	SELL	$22.49 - $34.56 $288,681 - $443,612	-12,836 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$20.44 - $35.56 $262,367 - $456,448	12,836	12,836 $346,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.